Clinical trial
Adderall XR Compared With Concerta in Treating Young Cancer Patients With…
NCT00069927 · University of South Florida, Other · Terminated
Key facts
| NCT number | NCT00069927 |
|---|---|
| Title | Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression |
| Official title | Adderall-XR Versus Concerta For Cancer Treatment-Related Neurocognitive Sequelae And Depression In Pediatric Patients: A Randomized Phase II Study |
| Lead sponsor | University of South Florida, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Depression, Neurotoxicity, Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | Adderall-XR®, Concerta® |
| Enrollment | 12 |
| Start date | Aug 1, 2003 |
| Primary completion | Jun 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Oct 7, 2003 |
| Last update posted | Feb 3, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: